Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1974 1
1975 8
1976 9
1977 16
1978 6
1979 9
1980 13
1981 15
1982 10
1983 12
1984 24
1985 12
1986 11
1987 11
1988 14
1989 14
1990 10
1991 17
1992 15
1993 6
1994 14
1995 14
1996 9
1997 16
1998 14
1999 10
2000 10
2001 13
2002 17
2003 15
2004 12
2005 13
2006 8
2007 10
2008 11
2009 9
2010 12
2011 7
2012 8
2013 3
2014 4
2015 5
2016 4
2017 5
2018 5
2019 1
2020 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

473 results

Results by year

Filters applied: . Clear all
Page 1
Estramustine phosphate sodium.
Hauser AR, Merryman R. Hauser AR, et al. Drug Intell Clin Pharm. 1984 May;18(5):368-74. doi: 10.1177/106002808401800502. Drug Intell Clin Pharm. 1984. PMID: 6373212 Review.
Estramustine phosphate is approved by the Food and Drug Administration for oral use in the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate. ...Although its therapeutic efficacy has been demonstrated, it is not clear to w …
Estramustine phosphate is approved by the Food and Drug Administration for oral use in the palliative treatment of patients wi …
The use of estramustine phosphate in the modern management of advanced prostate cancer.
Ravery V, Fizazi K, Oudard S, Drouet L, Eymard JC, Culine S, Gravis G, Hennequin C, Zerbib M. Ravery V, et al. BJU Int. 2011 Dec;108(11):1782-6. doi: 10.1111/j.1464-410X.2011.10201.x. Epub 2011 Jul 14. BJU Int. 2011. PMID: 21756277 Review.
What's known on the subject? and What does the study add? Estramustine phosphate has anti-tumour properties and it improves patient outcomes if combined with other chemotherapy agents such as docetaxel. ...OBJECTIVES: Estramustine phosphate is a nitrog …
What's known on the subject? and What does the study add? Estramustine phosphate has anti-tumour properties and it improves pa …
Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.
Perry CM, McTavish D. Perry CM, et al. Drugs Aging. 1995 Jul;7(1):49-74. doi: 10.2165/00002512-199507010-00006. Drugs Aging. 1995. PMID: 7579781 Review.
Estramustine phosphate sodium (estramustine phosphate), a unique antitumour agent, is selectively taken up by prostate cells and exerts antineoplastic effects by interfering with microtubule of dynamics and by reducing plasma levels of testosterone. In …
Estramustine phosphate sodium (estramustine phosphate), a unique antitumour agent, is selectively taken up by pr …
Estramustine phosphate--historical overview.
Fex H, Högberg B, Könyves I. Fex H, et al. Urology. 1984 Jun;23(6 Suppl):4-5. doi: 10.1016/s0090-4295(84)80090-4. Urology. 1984. PMID: 6730141 No abstract available.
Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma.
Könyves I. Könyves I. Int Urol Nephrol. 1989;21(4):393-7. doi: 10.1007/BF02559635. Int Urol Nephrol. 1989. PMID: 2693392 Review.
This review presents the most important hormonal, cytotoxic and pharmacokinetic properties of estramustine phosphate. Furthermore the results of randomized Phase III trials are described in patients with hormone refractory prostatic cancer with and without previous …
This review presents the most important hormonal, cytotoxic and pharmacokinetic properties of estramustine phosphate. Furtherm …
Estramustine phosphate induces prostate cancer cell line PC3 apoptosis by down-regulating miR-31 levels.
Wei C, Pan Y, Huang H, Li YP. Wei C, et al. Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):40-45. doi: 10.26355/eurrev_201801_14098. Eur Rev Med Pharmacol Sci. 2018. PMID: 29364469 Free article.
MATERIALS AND METHODS: Estramustine phosphate was used to treat prostate cancer cell line PC3. ...MiR-31 over-expression inhibited estramustine phosphate induced PC3 cell apoptosis. CONCLUSIONS: Estramustine phosphate induces prostate can …
MATERIALS AND METHODS: Estramustine phosphate was used to treat prostate cancer cell line PC3. ...MiR-31 over-expression inhib …
Pharmacokinetics and pharmacodynamics of estramustine phosphate.
Bergenheim AT, Henriksson R. Bergenheim AT, et al. Clin Pharmacokinet. 1998 Feb;34(2):163-72. doi: 10.2165/00003088-199834020-00004. Clin Pharmacokinet. 1998. PMID: 9515186 Review.
Estramustine phosphate (estramustine phosphate sodium), a carbamate ester combining 17 beta-estradiol and nor-nitrogen mustard, is a cytotoxic drug used in the treatment of advanced prostatic carcinoma. ...This may have obscured results from earlier cl …
Estramustine phosphate (estramustine phosphate sodium), a carbamate ester combining 17 beta-estradiol and nor-ni …
Estramustine phosphate and other cytotoxic drugs in the treatment of poor prognostic advanced prostate cancer.
Janknegt RA. Janknegt RA. Prostate Suppl. 1992;4:105-10. doi: 10.1002/pros.2990210516. Prostate Suppl. 1992. PMID: 1574449 Review.
However, there is a lack of active compounds that do not show major toxicity. Estramustine phosphate (EMP) may be an exception. It is unusual because it combines hormonal and cytotoxic effects. ...
However, there is a lack of active compounds that do not show major toxicity. Estramustine phosphate (EMP) may be an exception …
Estramustine Phosphate Inhibits TGF-beta-Induced Mouse Macrophage Migration and Urokinase-Type Plasminogen Activator Production.
Mojsilovic SS, Mojsilovic S, Bjelica S, Santibanez JF. Mojsilovic SS, et al. Anal Cell Pathol (Amst). 2018 Sep 2;2018:3134102. doi: 10.1155/2018/3134102. eCollection 2018. Anal Cell Pathol (Amst). 2018. PMID: 30245956 Free PMC article.
Microtubule (MT) cytoskeleton dynamic plays a key role during the cell motility, and any interference on the MT network profoundly affects cell migration. In this study, by using estramustine phosphate (EP), which modifies MT stability, we analysed whether tubulin c …
Microtubule (MT) cytoskeleton dynamic plays a key role during the cell motility, and any interference on the MT network profoundly affects c …
473 results